Transcription factor GATA-1 is the central nuclear regulatory for erythroid development. Without GATA-1 erythroid precursors arrest at the pro-erythroblast stage and undergo apoptosis. During the formation of embryonic red blood cells in the developing yolk sac blood islands, GATA-1's function overlaps with that of GATA-2. Thus, a GATA-factor, either of the hematopoietic system. Uncovering how GATA-1 functions in transcriptional control and the nature of its target genes are both fundamental to our understanding of the molecular mechanisms responsible for hematopoietic development, erythropoiesis, and more generally lineage-specific differentiation. In the proposed studiers, aspects of GATA-1 structure will be related to in vivo function through gene targeting in the mouse. The contribution of GATA-1's N-finger to DNA-binding and function in vivo will be addressed by modification of amino acid residues that are involved in DNA contacts but not binding of the protein cofactor FOG-1. The potential roles of the putative N-terminal activation domain of GATA-1 and phosphorylation of specific serine residues will be examined by targeted knockin mutations and creation of mice. In the latter experiments, collaboration with the Lodish laboratory will reveal effects of mutation of specific serines on response to erythropoietin, cell survival, and STAT signaling. In a second area of studies, we will determine the in vivo role of a new GATA-1 target gene, ABC-me, in heme biosynthesis and erythropoiesis. The ABC-me gene encodes a mitochondrial transporter, believed to participate in heme biosynthesis. Through targeted mutation in the mouse and in culture mouse erythroleukemia cells, the requirement for ABC-me will be tested. Moreover, to pursue the genetics of ABC-me more broadly, we will isolate and study the zebrafish homologue in collaboration with the Zon laboratory. This work should provide a comprehensive assessment of the biology of this new GATA-1 regulated transporter.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL032262-20
Application #
6492325
Study Section
Project Start
1983-01-01
Project End
2006-06-30
Budget Start
Budget End
Support Year
20
Fiscal Year
2001
Total Cost
$241,412
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Liu, Nan; Hargreaves, Victoria V; Zhu, Qian et al. (2018) Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch. Cell 173:430-442.e17
Whitman, Jared C; Paw, Barry H; Chung, Jacky (2018) The role of ClpX in erythropoietic protoporphyria. Hematol Transfus Cell Ther 40:182-188
Mandelbaum, Joseph; Shestopalov, Ilya A; Henderson, Rachel E et al. (2018) Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma. J Exp Med 215:2673-2685
Kapp, Friedrich G; Perlin, Julie R; Hagedorn, Elliott J et al. (2018) Protection from UV light is an evolutionarily conserved feature of the haematopoietic niche. Nature 558:445-448
Yamauchi, Takuji; Masuda, Takeshi; Canver, Matthew C et al. (2018) Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS. Cancer Cell 33:386-400.e5
Gehrke, Jason M; Cervantes, Oliver; Clement, M Kendell et al. (2018) An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities. Nat Biotechnol 36:977-982
Blaser, Bradley W; Zon, Leonard I (2018) Making HSCs in vitro: don't forget the hemogenic endothelium. Blood 132:1372-1378
Kafina, Martin D; Paw, Barry H (2018) Using the Zebrafish as an Approach to Examine the Mechanisms of Vertebrate Erythropoiesis. Methods Mol Biol 1698:11-36
Clement, Kendell; Farouni, Rick; Bauer, Daniel E et al. (2018) AmpUMI: design and analysis of unique molecular identifiers for deep amplicon sequencing. Bioinformatics 34:i202-i210
Liu, Frances D; Tam, Kimberley; Pishesha, Novalia et al. (2018) Improving hematopoietic recovery through modeling and modulation of the mesenchymal stromal cell secretome. Stem Cell Res Ther 9:268

Showing the most recent 10 out of 215 publications